Orally Disintegrating Films
The ODFs place as an alternative in the market due to the consumer’s preference for a fast dissolving product over conventional tablets / capsules. The oral thin-film technology is still in the beginning stages and has bright future ahead because it fulfils all the need of patients Eventually, film formulations having drug/s will be commerciallylaunched using the oral film technology. However, for future growth point of view the oral thin film sector is well-positioned A/q to Technology catalyst and Root analysis firms ---$500M to $2 billion. In US market the OTC films of pain management and motion sickness arecommercialized. More importantly, prescription OTFs have now been approved in US, EU and Japan which are the three major regions. Theseapproved Rx films, have potential to dominate over other oral dosage forms of the same drugs. It seems that the value of the overall oral thin film market will grow significantly.